TipRanks
PharmaCielo (PCLOF)
OTHER OTC:PCLOF
US Market
PCLOF
PharmaCielo
RESEARCH TOOLSreports

PharmaCielo (PCLOF) Income Statement

90 Followers

PharmaCielo Income Statement

Last quarter (Q2 2026), PharmaCielo's total revenue was C$1.39M, an increase of 75.22% from the same quarter last year. In Q2, PharmaCielo's net income was C$-1.44M. See PharmaCielo’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Jun 24Mar 23Mar 22
Total Revenue
C$ 2.61MC$ 3.48MC$ 1.54MC$ 5.31MC$ 1.94M
Gross Profit
C$ 756.40KC$ 730.88KC$ -1.37MC$ 827.06KC$ -4.31M
Operating Expenses
C$ 4.58MC$ 730.88KC$ 8.33MC$ 12.26MC$ 20.89M
Depreciation and Amortization
C$ 997.68KC$ 1.27MC$ 1.41MC$ 1.58MC$ 1.32M
EBITDA
C$ -1.00MC$ -4.60MC$ -12.19MC$ -10.50MC$ -24.84M
Operating Income
C$ -3.82MC$ -4.90MC$ -9.70MC$ -11.46MC$ -25.46M
Other Income/Expenses
C$ -729.91KC$ -9.14MC$ -6.60MC$ -3.89MC$ -2.89M
Pretax Income
C$ -4.55MC$ -9.14MC$ -16.30MC$ -14.52MC$ -26.63M
Net Income
C$ -4.55MC$ -9.14MC$ -16.30MC$ -16.04MC$ -26.92M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.01C$ -0.10C$ -0.11C$ -0.18
Diluted EPS
C$ -0.03C$ -0.01C$ -0.10C$ -0.11C$ -0.18
Weighted Average Shares Outstanding
 187.98M 175.25M 160.08M 150.98M 145.64M
Weighted Average Shares Outstanding (Diluted)
 187.98M 175.25M 160.08M 150.98M 145.64M
Currency in CAD

PharmaCielo Earnings and Revenue History